Journal of Cancer Research and Therapeutics Close
 

Figure 1: (a) A549 single cell clone at 10× magnification, (b) immunocytochemistry of A549 cancer cells and clones for CD44 and CD24 expression, (c) the images were acquired and number of CD44+ and CD24−/low were counted in different fields for total 300 cells. Graphical representation of percentage cells positive for CD44+ and CD24−/low in A549 cancer cells and clones. *Significantly different when compared to A549 cancer cells (P < 0.001)

Figure 1: (a) A549 single cell clone at 10× magnification, (b) immunocytochemistry of A549 cancer cells and clones for CD44 and CD24 expression, (c) the images were acquired and number of CD44<sup>+</sup> and CD24<sup>−/low</sup> were counted in different fields for total 300 cells. Graphical representation of percentage cells positive for CD44<sup>+</sup> and CD24<sup>−/low</sup> in A549 cancer cells and clones. *Significantly different when compared to A549 cancer cells (<i>P</i> < 0.001)